BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Motiwala T, Ghoshal K, Das A, Majumder S, Weichenhan D, Wu YZ, Holman K, James SJ, Jacob ST, Plass C. Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas. Oncogene. 2003;22:6319-6331. [PMID: 14508512 DOI: 10.1038/sj.onc.1206750] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Zhu P, Wu X, Zhang R, Hsu C, Zhang Z, Tao WA. An Integrated Proteomic Strategy to Identify SHP2 Substrates. J Proteome Res . [DOI: 10.1021/acs.jproteome.2c00481] [Reference Citation Analysis]
2 Dong H, Xie C, Yao Z, Zhao R, Lin Y, Luo Y, Chen S, Qin Y, Chen Y, Zhang H. PTPRO-related CD8+ T-cell signatures predict prognosis and immunotherapy response in patients with breast cancer. Front Immunol 2022;13:947841. [DOI: 10.3389/fimmu.2022.947841] [Reference Citation Analysis]
3 Dong H, Du L, Cai S, Lin W, Chen C, Still M, Yao Z, Coppes RP, Pan Y, Zhang D, Gao S, Zhang H. Tyrosine Phosphatase PTPRO Deficiency in ERBB2-Positive Breast Cancer Contributes to Poor Prognosis and Lapatinib Resistance. Front Pharmacol 2022;13:838171. [DOI: 10.3389/fphar.2022.838171] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Xie F, Dong H, Zhang H. Regulatory Functions of Protein Tyrosine Phosphatase Receptor Type O in Immune Cells. Front Immunol 2021;12:783370. [PMID: 34880876 DOI: 10.3389/fimmu.2021.783370] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Fain JS, Loriot A, Diacofotaki A, Van Tongelen A, De Smet C. Transcriptional overlap links DNA hypomethylation with DNA hypermethylation at adjacent promoters in cancer. Sci Rep 2021;11:17346. [PMID: 34462486 DOI: 10.1038/s41598-021-96844-0] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
6 Mosca P, Robert A, Alberto JM, Meyer M, Kundu U, Hergalant S, Umoret R, Coelho D, Guéant JL, Leheup B, Dreumont N. Vitamin B12 Deficiency Dysregulates m6A mRNA Methylation of Genes Involved in Neurological Functions. Mol Nutr Food Res 2021;65:e2100206. [PMID: 34291881 DOI: 10.1002/mnfr.202100206] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Sheweita SA, Ammar RG, Sabra SA, Sultan AS. Letrozole and zoledronic acid changed signalling pathways involved in the apoptosis of breast cancer cells. J Taibah Univ Med Sci 2021;16:112-20. [PMID: 33603639 DOI: 10.1016/j.jtumed.2020.10.017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Yang YC, Sugden B. Epstein-Barr Virus Limits the Accumulation of IPO7, an Essential Gene Product. Front Microbiol 2021;12:643327. [PMID: 33664726 DOI: 10.3389/fmicb.2021.643327] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Jin K, Liu Y, Shi Y, Zhang H, Sun Y, Zhangyuan G, Wang F, Yu W, Wang J, Tao X, Chen X, Zhang W, Sun B. PTPROt aggravates inflammation by enhancing NF-κB activation in liver macrophages during nonalcoholic steatohepatitis. Theranostics 2020;10:5290-304. [DOI: 10.7150/thno.42658] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
10 Hou X, Rooklin D, Yang D, Liang X, Li K, Lu J, Wang C, Xiao P, Zhang Y, Sun JP, Fang H. Computational Strategy for Bound State Structure Prediction in Structure-Based Virtual Screening: A Case Study of Protein Tyrosine Phosphatase Receptor Type O Inhibitors. J Chem Inf Model 2018;58:2331-42. [PMID: 30299094 DOI: 10.1021/acs.jcim.8b00548] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wang H, Baladandayuthapani V, Wang Z, Lin H, Berkova Z, Davis RE, Yang L, Orlowski RZ. Truncated protein tyrosine phosphatase receptor type O suppresses AKT signaling through IQ motif containing GTPase activating protein 1 and confers sensitivity to bortezomib in multiple myeloma. Oncotarget 2017;8:113858-73. [PMID: 29371952 DOI: 10.18632/oncotarget.23017] [Reference Citation Analysis]
12 Meeusen B, Janssens V. Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification. Int J Biochem Cell Biol 2018;96:98-134. [PMID: 29031806 DOI: 10.1016/j.biocel.2017.10.002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 8.0] [Reference Citation Analysis]
13 Ming F, Sun Q. Epigenetically silenced PTPRO functions as a prognostic marker and tumor suppressor in human lung squamous cell carcinoma. Mol Med Rep 2017;16:746-54. [PMID: 28586036 DOI: 10.3892/mmr.2017.6665] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
14 Zeisel S. Choline, Other Methyl-Donors and Epigenetics. Nutrients 2017;9:E445. [PMID: 28468239 DOI: 10.3390/nu9050445] [Cited by in Crossref: 73] [Cited by in F6Publishing: 76] [Article Influence: 14.6] [Reference Citation Analysis]
15 Wakim J, Arman E, Becker-Herman S, Kramer MP, Bakos E, Shachar I, Elson A. The PTPROt tyrosine phosphatase functions as an obligate haploinsufficient tumor suppressor in vivo in B-cell chronic lymphocytic leukemia. Oncogene 2017;36:3686-94. [PMID: 28166196 DOI: 10.1038/onc.2016.523] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
16 Bollu LR, Mazumdar A, Savage MI, Brown PH. Molecular Pathways: Targeting Protein Tyrosine Phosphatases in Cancer. Clin Cancer Res 2017;23:2136-42. [PMID: 28087641 DOI: 10.1158/1078-0432.CCR-16-0934] [Cited by in Crossref: 60] [Cited by in F6Publishing: 69] [Article Influence: 12.0] [Reference Citation Analysis]
17 Dong H, Ma L, Gan J, Lin W, Chen C, Yao Z, Du L, Zheng L, Ke C, Huang X, Song H, Kumar R, Yeung SC, Zhang H. PTPRO represses ERBB2-driven breast oncogenesis by dephosphorylation and endosomal internalization of ERBB2. Oncogene 2017;36:410-22. [PMID: 27345410 DOI: 10.1038/onc.2016.213] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
18 Zhang W, Hou J, Wang X, Jiang R, Yin Y, Ji J, Deng L, Huang X, Wang K, Sun B. PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis. Oncotarget. 2015;6:9420-9433. [PMID: 25826083 DOI: 10.18632/oncotarget.3353] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
19 Thummuri D, Kumar S, Surapaneni SK, Tikoo K. Epigenetic regulation of protein tyrosine phosphatase PTPN12 in triple-negative breast cancer. Life Sciences 2015;130:73-80. [DOI: 10.1016/j.lfs.2015.03.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
20 Motiwala T, Kutay H, Zanesi N, Frissora FW, Mo X, Muthusamy N, Jacob ST. PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse model. Leukemia 2015;29:1350-9. [PMID: 25482129 DOI: 10.1038/leu.2014.341] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
21 Du Y, Grandis JR. Receptor-type protein tyrosine phosphatases in cancer. Chin J Cancer 2015;34:61-9. [PMID: 25322863 DOI: 10.5732/cjc.014.10146] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
22 Li SY, Li R, Chen YL, Xiong LK, Wang HL, Rong L, Luo RC. Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients. BMC Genet 2014;15:67. [PMID: 24919593 DOI: 10.1186/1471-2156-15-67] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
23 Shi L, Feng Y, Lin H, Ma R, Cai X. Role of estrogen in hepatocellular carcinoma: is inflammation the key? J Transl Med. 2014;12:93. [PMID: 24708807 DOI: 10.1186/1479-5876-12-93] [Cited by in Crossref: 64] [Cited by in F6Publishing: 71] [Article Influence: 8.0] [Reference Citation Analysis]
24 Wang B, Hsu SH, Wang X, Kutay H, Bid HK, Yu J, Ganju RK, Jacob ST, Yuneva M, Ghoshal K. Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2. Hepatology 2014;59:555-66. [PMID: 24038073 DOI: 10.1002/hep.26712] [Cited by in Crossref: 77] [Cited by in F6Publishing: 76] [Article Influence: 9.6] [Reference Citation Analysis]
25 Hsu SH, Motiwala T, Roy S, Claus R, Mustafa M, Plass C, Freitas MA, Ghoshal K, Jacob ST. Methylation of the PTPRO gene in human hepatocellular carcinoma and identification of VCP as its substrate. J Cell Biochem 2013;114:1810-8. [PMID: 23533167 DOI: 10.1002/jcb.24525] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
26 Hou J, Xia Y, Jiang R, Chen D, Xu J, Deng L, Huang X, Wang X, Sun B. PTPRO plays a dual role in hepatic ischemia reperfusion injury through feedback activation of NF-κB. J Hepatol. 2014;60:306-312. [PMID: 24128416 DOI: 10.1016/j.jhep.2013.09.028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
27 Huang YT, Li FF, Ke C, Li Z, Li ZT, Zou XF, Zheng XX, Chen YP, Zhang H. PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy. J Transl Med 2013;11:245. [PMID: 24090193 DOI: 10.1186/1479-5876-11-245] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
28 Sun PH, Ye L, Mason MD, Jiang WG. Protein tyrosine phosphatase kappa (PTPRK) is a negative regulator of adhesion and invasion of breast cancer cells, and associates with poor prognosis of breast cancer. J Cancer Res Clin Oncol 2013;139:1129-39. [PMID: 23552869 DOI: 10.1007/s00432-013-1421-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
29 Hou J, Xu J, Jiang R, Wang Y, Chen C, Deng L, Huang X, Wang X, Sun B. Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3. Hepatology 2013;57:678-88. [PMID: 22821478 DOI: 10.1002/hep.25980] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 5.2] [Reference Citation Analysis]
30 Laczmanska I, Karpinski P, Bebenek M, Sedziak T, Ramsey D, Szmida E, Sasiadek MM. Protein tyrosine phosphatase receptor-like genes are frequently hypermethylated in sporadic colorectal cancer. J Hum Genet. 2013;58:11-15. [PMID: 23096495 DOI: 10.1038/jhg.2012.119] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
31 Kutay H, Klepper C, Wang B, Hsu SH, Datta J, Yu L, Zhang X, Majumder S, Motiwala T, Khan N, Belury M, McClain C, Jacob S, Ghoshal K. Reduced susceptibility of DNA methyltransferase 1 hypomorphic (Dnmt1N/+) mice to hepatic steatosis upon feeding liquid alcohol diet. PLoS One 2012;7:e41949. [PMID: 22905112 DOI: 10.1371/journal.pone.0041949] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
32 Yu M, Lin G, Arshadi N, Kalatskaya I, Xue B, Haider S, Nguyen F, Boutros PC, Elson A, Muthuswamy LB, Tonks NK, Muthuswamy SK. Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation. Mol Cell Biol 2012;32:3913-24. [PMID: 22851698 DOI: 10.1128/MCB.00068-12] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
33 Pogribny IP. MicroRNA dysregulation during chemical carcinogenesis. Epigenomics 2009;1:281-90. [PMID: 22122703 DOI: 10.2217/epi.09.17] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
34 Lau KH, Stiffel V, Amoui M. An osteoclastic protein-tyrosine phosphatase regulates the β3-integrin, syk, and shp1 signaling through respective src-dependent phosphorylation in osteoclasts. Am J Physiol Cell Physiol 2012;302:C1676-86. [PMID: 22460711 DOI: 10.1152/ajpcell.00042.2012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
35 Ciappio ED, Mason JB, Crott JW. Maternal one-carbon nutrient intake and cancer risk in offspring. Nutr Rev 2011;69:561-71. [PMID: 21967157 DOI: 10.1111/j.1753-4887.2011.00424.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
36 Pogribny IP, James SJ, Beland FA. Molecular alterations in hepatocarcinogenesis induced by dietary methyl deficiency. Mol Nutr Food Res 2012;56:116-25. [DOI: 10.1002/mnfr.201100524] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 4.7] [Reference Citation Analysis]
37 Hogan LE, Meyer JA, Yang J, Wang J, Wong N, Yang W, Condos G, Hunger SP, Raetz E, Saffery R. Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. Blood. 2011;118:5218-5226. [PMID: 21921043 DOI: 10.1182/blood-2011-04-345595] [Cited by in Crossref: 136] [Cited by in F6Publishing: 141] [Article Influence: 12.4] [Reference Citation Analysis]
38 You YJ, Chen YP, Zheng XX, Meltzer SJ, Zhang H. Aberrant methylation of the PTPRO gene in peripheral blood as a potential biomarker in esophageal squamous cell carcinoma patients. Cancer Lett 2012;315:138-44. [PMID: 22099875 DOI: 10.1016/j.canlet.2011.08.032] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
39 Motiwala T, Datta J, Kutay H, Roy S, Jacob ST. Lyn kinase and ZAP70 are substrates of PTPROt in B-cells: Lyn inactivation by PTPROt sensitizes leukemia cells to VEGF-R inhibitor pazopanib. J Cell Biochem 2010;110:846-56. [PMID: 20564182 DOI: 10.1002/jcb.22593] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
40 Tryndyak VP, Han T, Muskhelishvili L, Fuscoe JC, Ross SA, Beland FA, Pogribny IP. Coupling global methylation and gene expression profiles reveal key pathophysiological events in liver injury induced by a methyl-deficient diet. Mol Nutr Food Res. 2011;55:411-418. [PMID: 20938992 DOI: 10.1002/mnfr.201000300] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
41 Samuelsson JK, Alonso S, Yamamoto F, Perucho M. DNA fingerprinting techniques for the analysis of genetic and epigenetic alterations in colorectal cancer. Mutat Res 2010;693:61-76. [PMID: 20851135 DOI: 10.1016/j.mrfmmm.2010.08.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
42 Asada K, Kotake Y, Asada R, Saunders D, Broyles RH, Towner RA, Fukui H, Floyd RA. LINE-1 hypomethylation in a choline-deficiency-induced liver cancer in rats: dependence on feeding period. J Biomed Biotechnol. 2006;2006:17142. [PMID: 16877811 DOI: 10.1155/jbb/2006/17142] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
43 Cheung HH, Lee TL, Rennert OM, Chan WY. DNA methylation of cancer genome. Birth Defects Res C Embryo Today 2009;87:335-50. [PMID: 19960550 DOI: 10.1002/bdrc.20163] [Cited by in Crossref: 90] [Cited by in F6Publishing: 84] [Article Influence: 7.5] [Reference Citation Analysis]
44 Menigatti M, Cattaneo E, Sabates-Bellver J, Ilinsky VV, Went P, Buffoli F, Marquez VE, Jiricny J, Marra G. The protein tyrosine phosphatase receptor type R gene is an early and frequent target of silencing in human colorectal tumorigenesis. Mol Cancer 2009;8:124. [PMID: 20015382 DOI: 10.1186/1476-4598-8-124] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
45 Juszczynski P, Chen L, O'Donnell E, Polo JM, Ranuncolo SM, Dalla-Favera R, Melnick A, Shipp MA. BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt. Blood 2009;114:5315-21. [PMID: 19855081 DOI: 10.1182/blood-2009-02-204362] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 3.5] [Reference Citation Analysis]
46 Sheng MH, Lau KH. Role of protein-tyrosine phosphatases in regulation of osteoclastic activity. Cell Mol Life Sci 2009;66:1946-61. [PMID: 19189046 DOI: 10.1007/s00018-009-8811-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
47 Gobert RP, van den Eijnden M, Szyndralewiez C, Jorand-Lebrun C, Swinnen D, Chen L, Gillieron C, Pixley F, Juillard P, Gerber P, Johnson-Léger C, Halazy S, Camps M, Bombrun A, Shipp M, Vitte PA, Ardissone V, Ferrandi C, Perrin D, Rommel C, Hooft van Huijsduijnen R. GLEPP1/protein-tyrosine phosphatase phi inhibitors block chemotaxis in vitro and in vivo and improve murine ulcerative colitis. J Biol Chem 2009;284:11385-95. [PMID: 19233845 DOI: 10.1074/jbc.M807241200] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
48 Ramaswamy B, Majumder S, Roy S, Ghoshal K, Kutay H, Datta J, Younes M, Shapiro CL, Motiwala T, Jacob ST. Estrogen-mediated suppression of the gene encoding protein tyrosine phosphatase PTPRO in human breast cancer: mechanism and role in tamoxifen sensitivity. Mol Endocrinol 2009;23:176-87. [PMID: 19095770 DOI: 10.1210/me.2008-0211] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
49 Motiwala T, Majumder S, Ghoshal K, Kutay H, Datta J, Roy S, Lucas DM, Jacob ST. PTPROt inactivates the oncogenic fusion protein BCR/ABL and suppresses transformation of K562 cells. J Biol Chem 2009;284:455-64. [PMID: 18997174 DOI: 10.1074/jbc.M802840200] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
50 Datta J, Kutay H, Nasser MW, Nuovo GJ, Wang B, Majumder S, Liu CG, Volinia S, Croce CM, Schmittgen TD. Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res. 2008;68:5049-5058. [PMID: 18593903 DOI: 10.1158/0008-5472.can-07-6655] [Cited by in Crossref: 337] [Cited by in F6Publishing: 330] [Article Influence: 24.1] [Reference Citation Analysis]
51 Xu X, Hong Y, Kong C, Xu L, Tan J, Liang Q, Huang B, Lu J. Protein tyrosine phosphatase receptor-type O (PTPRO) is co-regulated by E2F1 and miR-17-92. FEBS Letters 2008;582:2850-6. [DOI: 10.1016/j.febslet.2008.07.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
52 Pogribny IP, Rusyn I, Beland FA. Epigenetic aspects of genotoxic and non-genotoxic hepatocarcinogenesis: studies in rodents. Environ Mol Mutagen 2008;49:9-15. [PMID: 17879298 DOI: 10.1002/em.20342] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
53 Granot-Attas S, Elson A. Protein tyrosine phosphatases in osteoclast differentiation, adhesion, and bone resorption. Eur J Cell Biol 2008;87:479-90. [PMID: 18342392 DOI: 10.1016/j.ejcb.2008.01.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
54 Wang JF, Dai DQ. Metastatic suppressor genes inactivated by aberrant methylation in gastric cancer. World J Gastroenterol 2007; 13(43): 5692-5698 [PMID: 17963294 DOI: 10.3748/wjg.v13.i43.5692] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
55 Girish TS, Gopal B. The crystal structure of the catalytic domain of the chick retinal neurite inhibitor-receptor protein tyrosine phosphatase CRYP-2/cPTPRO. Proteins 2007;68:1011-5. [PMID: 17546659 DOI: 10.1002/prot.21424] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
56 Motiwala T, Majumder S, Kutay H, Smith DS, Neuberg DS, Lucas DM, Byrd JC, Grever M, Jacob ST. Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia. Clin Cancer Res 2007;13:3174-81. [PMID: 17545520 DOI: 10.1158/1078-0432.CCR-06-1720] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 3.0] [Reference Citation Analysis]
57 Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, Frankel W, Jacob ST, Ghoshal K. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem. 2006;99:671-678. [PMID: 16924677 DOI: 10.1002/jcb.20982] [Cited by in Crossref: 422] [Cited by in F6Publishing: 402] [Article Influence: 28.1] [Reference Citation Analysis]
58 Motiwala T, Jacob ST. Role of protein tyrosine phosphatases in cancer. Prog Nucleic Acid Res Mol Biol 2006;81:297-329. [PMID: 16891175 DOI: 10.1016/S0079-6603(06)81008-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
59 Ho SM, Tang WY. Techniques used in studies of epigenome dysregulation due to aberrant DNA methylation: an emphasis on fetal-based adult diseases. Reprod Toxicol. 2007;23:267-282. [PMID: 17317097 DOI: 10.1016/j.reprotox.2007.01.004] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 3.8] [Reference Citation Analysis]
60 Tonks NK. Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol. 2006;7:833-846. [PMID: 17057753 DOI: 10.1038/nrm2039] [Cited by in Crossref: 1070] [Cited by in F6Publishing: 1053] [Article Influence: 66.9] [Reference Citation Analysis]
61 Chen L, Juszczynski P, Takeyama K, Aguiar RC, Shipp MA. Protein tyrosine phosphatase receptor-type O truncated (PTPROt) regulates SYK phosphorylation, proximal B-cell-receptor signaling, and cellular proliferation. Blood 2006;108:3428-33. [PMID: 16888096 DOI: 10.1182/blood-2006-03-013821] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 4.1] [Reference Citation Analysis]
62 Tautz L, Pellecchia M, Mustelin T. Targeting the PTPome in human disease. Expert Opin Ther Targets 2006;10:157-77. [PMID: 16441235 DOI: 10.1517/14728222.10.1.157] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 4.6] [Reference Citation Analysis]
63 Ghoshal K, Li X, Datta J, Bai S, Pogribny I, Pogribny M, Huang Y, Young D, Jacob ST. A folate- and methyl-deficient diet alters the expression of DNA methyltransferases and methyl CpG binding proteins involved in epigenetic gene silencing in livers of F344 rats. J Nutr 2006;136:1522-7. [PMID: 16702315 DOI: 10.1093/jn/136.6.1522] [Cited by in Crossref: 147] [Cited by in F6Publishing: 123] [Article Influence: 9.2] [Reference Citation Analysis]
64 Ostman A, Hellberg C, Böhmer FD. Protein-tyrosine phosphatases and cancer. Nat Rev Cancer 2006;6:307-20. [PMID: 16557282 DOI: 10.1038/nrc1837] [Cited by in Crossref: 432] [Cited by in F6Publishing: 431] [Article Influence: 27.0] [Reference Citation Analysis]
65 Bai S, Ghoshal K, Jacob ST. Identification of T-cadherin as a novel target of DNA methyltransferase 3B and its role in the suppression of nerve growth factor-mediated neurite outgrowth in PC12 cells. J Biol Chem 2006;281:13604-11. [PMID: 16537533 DOI: 10.1074/jbc.M513278200] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
66 Pogribny IP, Ross SA, Tryndyak VP, Pogribna M, Poirier LA, Karpinets TV. Histone H3 lysine 9 and H4 lysine 20 trimethylation and the expression of Suv4-20h2 and Suv-39h1 histone methyltransferases in hepatocarcinogenesis induced by methyl deficiency in rats. Carcinogenesis. 2006;27:1180-1186. [PMID: 16497704 DOI: 10.1093/carcin/bgi364] [Cited by in Crossref: 107] [Cited by in F6Publishing: 79] [Article Influence: 6.7] [Reference Citation Analysis]
67 Brena RM, Huang TH, Plass C. Quantitative assessment of DNA methylation: potential applications for disease diagnosis, classification, and prognosis in clinical settings. J Mol Med 2006;84:365-77. [DOI: 10.1007/s00109-005-0034-0] [Cited by in Crossref: 68] [Cited by in F6Publishing: 54] [Article Influence: 4.3] [Reference Citation Analysis]
68 Toyota M, Issa JP. Epigenetic changes in solid and hematopoietic tumors. Semin Oncol 2005;32:521-30. [PMID: 16210093 DOI: 10.1053/j.seminoncol.2005.07.003] [Cited by in Crossref: 89] [Cited by in F6Publishing: 71] [Article Influence: 5.2] [Reference Citation Analysis]
69 Jacob ST, Motiwala T. Epigenetic regulation of protein tyrosine phosphatases: potential molecular targets for cancer therapy. Cancer Gene Ther 2005;12:665-72. [PMID: 15803146 DOI: 10.1038/sj.cgt.7700828] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 2.8] [Reference Citation Analysis]
70 Ghoshal K, Datta J, Majumder S, Bai S, Kutay H, Motiwala T, Jacob ST. 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal. Mol Cell Biol 2005;25:4727-41. [PMID: 15899874 DOI: 10.1128/MCB.25.11.4727-4741.2005] [Cited by in Crossref: 311] [Cited by in F6Publishing: 300] [Article Influence: 18.3] [Reference Citation Analysis]
71 Utsunomiya T, Ogawa K, Yoshinaga K, Ohta M, Yamashita K, Mimori K, Inoue H, Ezaki T, Yoshikawa Y, Mori M. Clinicopathologic and prognostic values of apolipoprotein D alterations in hepatocellular carcinoma. Int J Cancer. 2005;116:105-109. [PMID: 15756681 DOI: 10.1002/ijc.20986] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
72 van Doorn R, Zoutman WH, Dijkman R, de Menezes RX, Commandeur S, Mulder AA, van der Velden PA, Vermeer MH, Willemze R, Yan PS. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73. J Clin Oncol. 2005;23:3886-3896. [PMID: 15897551 DOI: 10.1200/jco.2005.11.353] [Cited by in Crossref: 167] [Cited by in F6Publishing: 150] [Article Influence: 9.8] [Reference Citation Analysis]
73 Bai S, Ghoshal K, Datta J, Majumder S, Yoon SO, Jacob ST. DNA methyltransferase 3b regulates nerve growth factor-induced differentiation of PC12 cells by recruiting histone deacetylase 2. Mol Cell Biol. 2005;25:751-766. [PMID: 15632075 DOI: 10.1128/mcb.25.2.751-766.2005] [Cited by in Crossref: 77] [Cited by in F6Publishing: 75] [Article Influence: 4.5] [Reference Citation Analysis]
74 Feitelson MA. c-myc overexpression in hepatocarcinogenesis. Human Pathology 2004;35:1299-302. [DOI: 10.1016/j.humpath.2004.09.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
75 Motiwala T, Kutay H, Ghoshal K, Bai S, Seimiya H, Tsuruo T, Suster S, Morrison C, Jacob ST. Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer. Proc Natl Acad Sci U S A 2004;101:13844-9. [PMID: 15356345 DOI: 10.1073/pnas.0405451101] [Cited by in Crossref: 79] [Cited by in F6Publishing: 76] [Article Influence: 4.4] [Reference Citation Analysis]
76 Ghoshal K, Majumder S, Datta J, Motiwala T, Bai S, Sharma SM, Frankel W, Jacob ST. Role of human ribosomal RNA (rRNA) promoter methylation and of methyl-CpG-binding protein MBD2 in the suppression of rRNA gene expression. J Biol Chem 2004;279:6783-93. [PMID: 14610093 DOI: 10.1074/jbc.M309393200] [Cited by in Crossref: 138] [Cited by in F6Publishing: 129] [Article Influence: 7.3] [Reference Citation Analysis]